892
Views
26
CrossRef citations to date
0
Altmetric
Drug Discovery Case History

The discovery and development of romidepsin for the treatment of T-cell lymphoma

&
Pages 859-873 | Received 03 Mar 2017, Accepted 08 Jun 2017, Published online: 22 Jun 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Farheen Manji, Robert Puckrin & Douglas A. Stewart. (2021) Novel synthetic drugs for the treatment of non-Hodgkin lymphoma. Expert Opinion on Pharmacotherapy 22:11, pages 1417-1427.
Read now
Edward R. Sauter. (2020) Cancer prevention and treatment using combination therapy with natural compounds. Expert Review of Clinical Pharmacology 13:3, pages 265-285.
Read now
Mauro Alaibac. (2018) Small molecule inhibitors for cutaneous T-cell lymphomas. Expert Opinion on Orphan Drugs 6:5, pages 345-350.
Read now

Articles from other publishers (23)

Vandana Joshi & Navneeta Bharadvaja. (2023) Current Prospects and Clinical Status of Microalgae Derived Chemotherapeutics. Revista Brasileira de Farmacognosia 33:3, pages 445-470.
Crossref
Beatriz Silva Urias, Aline Renata Pavan, Gabriela Ribeiro Albuquerque, Igor Muccilo Prokopczyk, Tânia Mara Ferreira Alves, Thais Regina Ferreira de Melo, Geraldo Rodrigues Sartori, João Hermínio Martins da Silva, Chung Man Chin & Jean Leandro Dos Santos. (2022) Optimization of Resveratrol Used as a Scaffold to Design Histone Deacetylase (HDAC-1 and HDAC-2) Inhibitors. Pharmaceuticals 15:10, pages 1260.
Crossref
Jingru Yang, Cong Song & Xianquan Zhan. (2022) The role of protein acetylation in carcinogenesis and targeted drug discovery. Frontiers in Endocrinology 13.
Crossref
Jiayu Wang, Jiaxing Li, Xin Zhang, Min Zhang, Xiaopeng Hu & Hang Yin. (2022) Molecular mechanisms of histone deacetylases and inhibitors in renal fibrosis progression. Frontiers in Molecular Biosciences 9.
Crossref
Kubra Acikalin Coskun, Merve Tutar, Elif Cansu Abay, Nazlican Yurekli, Mervenur Al & Yusuf Tutar. 2022. Lymphoma. Lymphoma.
Jiaxin Liu, Jia-nan Li, Hongyu Wu & Panpan Liu. (2022) The Status and Prospects of Epigenetics in the Treatment of Lymphoma. Frontiers in Oncology 12.
Crossref
Nabanita Nawar, Shazreh Bukhari, Ashley A. Adile, Yujin Suk, Pimyupa Manaswiyoungkul, Krimo Toutah, Olasunkanmi O. Olaoye, Yasir S. Raouf, Abootaleb Sedighi, Harsimran Kaur Garcha, Muhammad Murtaza Hassan, William Gwynne, Johan Israelian, Tudor B. Radu, Mulu Geletu, Ayah Abdeldayem, Justyna M. Gawel, Aaron D. Cabral, Chitra Venugopal, Elvin D. de Araujo, Sheila K. Singh & Patrick T. Gunning. (2022) Discovery of HDAC6-Selective Inhibitor NN-390 with in Vitro Efficacy in Group 3 Medulloblastoma . Journal of Medicinal Chemistry 65:4, pages 3193-3217.
Crossref
Jun Du, Xinle Han, Suwen Lin, Chen Qiu, Lijun Zhu, Zoufang Huang & Jian Hou. (2021) Efficacy and Treatment-Related Adverse Events of Romidepsin in PTCL Clinical Studies: A Systematic Review and Meta-Analysis. Frontiers in Medicine 8.
Crossref
Alain Chebly, Martina Prochazkova-Carlotti, Yamina Idrissi, Laurence Bresson-Bepoldin, Sandrine Poglio, Chantal Farra, Marie Beylot-Barry, Jean-Philippe Merlio, Roland Tomb & Edith Chevret. (2021) Targeting Epigenetic Modifiers Can Reduce the Clonogenic Capacities of Sézary Cells. Frontiers in Oncology 11.
Crossref
Ping Zhang & Mingzhi Zhang. (2021) Epigenetics in the Pathogenesis and Treatment of Cutaneous T-Cell Lymphoma. Frontiers in Oncology 11.
Crossref
Xin-le Han, Jun Du, Ya-dan Zheng, Jia-jing Dai, Su-wen Lin, Bing-yue Zhang, Fu-bo Zhong, Zhe-guang Lin, Shu-qi Jiang, Wei Wei & Zheng-yu Fang. (2021) CXCL1 Clone Evolution Induced by the HDAC Inhibitor Belinostat Might Be a Favorable Prognostic Indicator in Triple-Negative Breast Cancer. BioMed Research International 2021, pages 1-12.
Crossref
Katie Dunphy, Paul Dowling, Despina Bazou & Peter O’Gorman. (2021) Current Methods of Post-Translational Modification Analysis and Their Applications in Blood Cancers. Cancers 13:8, pages 1930.
Crossref
Kuojun Zhang, Zhiyi Liu, Yiwu Yao, Yatao Qiu, Feng Li, Dong Chen, Dale J. Hamilton, Zheng Li & Sheng Jiang. (2021) Structure-Based Design of a Selective Class I Histone Deacetylase (HDAC) Near-Infrared (NIR) Probe for Epigenetic Regulation Detection in Triple-Negative Breast Cancer (TNBC). Journal of Medicinal Chemistry 64:7, pages 4020-4033.
Crossref
Kumari Asha & Neelam Sharma-Walia. (2021) Targeting Host Cellular Factors as a Strategy of Therapeutic Intervention for Herpesvirus Infections. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Yu Peng, Hongxun Tao, Yuanqing Gao, Yuanyuan Yang & Zhiyong Chen. (2021) Review and Prospect of Tissue-agnostic Targeted Strategies in Anticancer Therapies. Current Topics in Medicinal Chemistry 21:5, pages 404-425.
Crossref
Eftiola Pojani & Daniela Barlocco. (2021) Romidepsin (FK228), A Histone Deacetylase Inhibitor and its Analogues in Cancer Chemotherapy. Current Medicinal Chemistry 28:7, pages 1290-1303.
Crossref
Auris Huen, Bradley M. Haverkos, Jasmine Zain, Ramchandren Radhakrishnan, Mary Jo Lechowicz, Sumana Devata, Neil J. Korman, Lauren Pinter-Brown, Yasuhiro Oki, Prajak J. Barde, Ajit Nair, Kasi Viswanath Routhu, Srikant Viswanadha, Swaroop Vakkalanka & Swaminathan P. Iyer. (2020) Phase I/Ib Study of Tenalisib (RP6530), a Dual PI3K δ/γ Inhibitor in Patients with Relapsed/Refractory T-Cell Lymphoma. Cancers 12:8, pages 2293.
Crossref
Jianqiao He, Xin Wei, Zhijie Yang, Yan Li, Jianhua Ju & Junying Ma. (2020) Characterization of Regulatory and Transporter Genes in the Biosynthesis of Anti-Tuberculosis Ilamycins and Production in a Heterologous Host. Marine Drugs 18:4, pages 216.
Crossref
Anas Najjar, Abderrahman Najjar & Rafik Karaman. (2020) Newly Developed Prodrugs and Prodrugs in Development; an Insight of the Recent Years. Molecules 25:4, pages 884.
Crossref
Hassell. (2019) Histone Deacetylases and their Inhibitors in Cancer Epigenetics. Diseases 7:4, pages 57.
Crossref
Patrick G. Dougherty, Ashweta Sahni & Dehua Pei. (2019) Understanding Cell Penetration of Cyclic Peptides. Chemical Reviews 119:17, pages 10241-10287.
Crossref
Raúl G. Saraiva, Callie R. Huitt-Roehl, Abhai Tripathi, Yi-Qiang Cheng, Jürgen Bosch, Craig A. Townsend & George Dimopoulos. (2018) Chromobacterium spp. mediate their anti-Plasmodium activity through secretion of the histone deacetylase inhibitor romidepsin. Scientific Reports 8:1.
Crossref
Nicole S L Yeo-Teh, Yoshiaki Ito & Sudhakar Jha. 2018. Gene Expression and Regulation in Mammalian Cells - Transcription Toward the Establishment of Novel Therapeutics. Gene Expression and Regulation in Mammalian Cells - Transcription Toward the Establishment of Novel Therapeutics.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.